StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012022 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Luca Giudice und 2 weiteren Autor:innen. Beteiligte Einrichtung: A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Computational Biology, Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Business Finland, Academy of Finland, European Union’s Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
The Patient Similarity Network paradigm implies modeling the similarity between patients based on specific data. The similarity can summarize patients’ relationships from high-dimensional data, such as biological omics. The end PSN can undergo un/supervised learning tasks while being strongly interpretable, tailored for precision medicine, and ready to be analyzed with graph-theory methods. However, these benefits are not guaranteed and depend on the granularity of the summarized data, the clarity of the similarity measure, the complexity of the network’s topology, and the implemented methods for analysis. To date, no patient classifier fully leverages the paradigm’s inherent benefits. PSNs remain complex, unexploited, and meaningless. We present StellarPath, a hierarchical-vertical patient classifier that leverages pathway analysis and patient similarity concepts to find meaningful features for both classes and individuals. StellarPath processes omics data, hierarchically integrates them into pathways, and uses a novel similarity to measure how patients’ pathway activity is alike. It selects biologically relevant molecules, pathways, and networks, considering molecule stability and topology. A graph convolutional neural network then predicts unknown patients based on known cases. StellarPath excels in classification performances and computational resources across sixteen datasets. It demonstrates proficiency in inferring the class of new patients described in external independent studies, following its initial training and testing phases on a local dataset. It advances the PSN paradigm and provides new markers, insights, and tools for in-depth patient profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
ORCID-Profile: Luca Giudice, Ahmed Mohamed, Tarja Malm
Förderung
- Business Finland
- Academy of Finland
- European Union’s Horizon 2020 research and innovation programme
- European Union’s Horizon 2020 research and innovation
Zitieren
APA
Giudice, L., Mohamed, A., & Malm, T. (2024). StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012022
Vancouver
Giudice L, Mohamed A, Malm T. StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012022
BibTeX
@article{Giudice2024,
author = {Giudice, Luca and Mohamed, Ahmed and Malm, Tarja},
title = {StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012022}
}
EUVIMED